Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Amicus Therapeutics (FOLD)

Amicus Therapeutics (FOLD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,631,334
  • Shares Outstanding, K 266,060
  • Annual Sales, $ 260,890 K
  • Annual Income, $ -276,850 K
  • 60-Month Beta 1.15
  • Price/Sales 10.23
  • Price/Cash Flow N/A
  • Price/Book 10.53
Trade FOLD with:

Options Overview

Details
  • Implied Volatility 54.40%
  • Historical Volatility 35.98%
  • IV Percentile 9%
  • IV Rank 10.79%
  • IV High 237.40% on 02/11/21
  • IV Low 32.26% on 07/24/20
  • Put/Call Vol Ratio 5.52
  • Today's Volume 515
  • Volume Avg (30-Day) 914
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 40,137
  • Open Int (30-Day) 41,718

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.21
  • Number of Estimates 4
  • High Estimate -0.20
  • Low Estimate -0.22
  • Prior Year -0.20
  • Growth Rate Est. (year over year) -5.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.68 +15.67%
on 05/25/21
10.84 -7.38%
on 06/14/21
+1.08 (+12.05%)
since 05/21/21
3-Month
8.68 +15.67%
on 05/25/21
10.84 -7.38%
on 06/14/21
-0.15 (-1.47%)
since 03/23/21
52-Week
8.68 +15.67%
on 05/25/21
25.39 -60.46%
on 12/22/20
-5.52 (-35.48%)
since 06/23/20

Most Recent Stories

More News
Amicus Therapeutics Appoints Eiry W. Roberts, M.D. to its Board of Directors

Amicus Therapeutics (Nasdaq: FOLD), today announced the election and appointment of Eiry W. Roberts, M.D. to its Board of Directors. Dr. Roberts is an esteemed drug developer who brings approximately 30...

FOLD : 10.04 (+1.52%)
Why Is Amicus Therapeutics (FOLD) Up 8.1% Since Last Earnings Report?

Amicus Therapeutics (FOLD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

FOLD : 10.04 (+1.52%)
Amicus Therapeutics Announces United Kingdom's MHRA Grants Early Access to AT-GAA

Permits All Eligible Individuals with Late-Onset Pompe Disease Access to AT-GAA Prior to Marketing Authorization in the UK

FOLD : 10.04 (+1.52%)
Amicus Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference

Amicus Therapeutics (Nasdaq: FOLD) today announced that members of the Amicus senior leadership team will participate in a fireside chat at the Goldman Sachs 42 Annual Global Healthcare Conference, being...

FOLD : 10.04 (+1.52%)
The Alliance for Artificial Intelligence in Healthcare Adds Google, Roche as Members to Advocate for Solutions to the World's Biggest Health Challenges

BALTIMORE, May 25, 2021

FOLD : 10.04 (+1.52%)
Amicus Therapeutics Announces Upcoming Presentations at the 16th International Congress on Neuromuscular Diseases

Amicus Therapeutics (Nasdaq: FOLD), today announced two posters for presentation highlighting its development program for Pompe disease at the 16th International Congress on Neuromuscular Diseases (ICNMD)...

FOLD : 10.04 (+1.52%)
Amicus' (FOLD) Q1 Loss Wider Than Expected, Sales Up Y/Y

Amicus (FOLD) reports a wider Q1 loss and sales miss estimates.

SNY : 52.08 (-0.42%)
RHHBY : 46.1300 (-1.43%)
FOLD : 10.04 (+1.52%)
TAK : 16.69 (-1.01%)
Amicus Therapeutics (FOLD) Reports Q1 Loss, Lags Revenue Estimates

Amicus Therapeutics (FOLD) delivered earnings and revenue surprises of -8.70% and -7.47%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

FOLD : 10.04 (+1.52%)
Amicus Therapeutics: Q1 Earnings Snapshot

CRANBURY, N.J. (AP) _ Amicus Therapeutics Inc. (FOLD) on Monday reported a loss of $65.7 million in its first quarter.

FOLD : 10.04 (+1.52%)
Amicus Therapeutics Announces First Quarter 2021 Financial Results and Corporate Updates

Galafold (migalastat) Performance Reflects Continued Strong Adoption in All Key Global Regions; On-Track to Achieve Revenue Guidance of $300M-$315M

FOLD : 10.04 (+1.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

AMICUS THERAPEUTICS is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilizeproteins in...

See More

Key Turning Points

3rd Resistance Point 10.39
2nd Resistance Point 10.23
1st Resistance Point 10.13
Last Price 10.04
1st Support Level 9.87
2nd Support Level 9.71
3rd Support Level 9.61

See More

52-Week High 25.39
Fibonacci 61.8% 19.01
Fibonacci 50% 17.03
Fibonacci 38.2% 15.06
Last Price 10.04
52-Week Low 8.68

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar